Fireworks and eye safety poll: Which injuries do ophthalmologists see most often?

Poll

A survey of fireworks-related injuries for ophthalmologists and retina specialists.

Fireworks and eye safety poll: Which injuries do ophthalmologists see most often?

Do you educate patients on the risks associated with fireworks?

Yes
No

How many fireworks-related ocular injuries do you treat per year?

None
1-5
6-10
11-20
21-30
31+
Unknown block type "pollMultiChoice", specify a component for it in the `components.types` prop

Related Content: Retinal Surgery | Ophthalmology | Retina in 2020 and Beyond

Related Videos
Related Content

ProQR Therapeutics offers update on sale of ophthalmic assets

September 29th 2023

Integrating AI to manage DR in a primary care setting

December 1st 2020

FDA approves RYZUMVI (Phentolamine Ophthalmic Solution) for the treatment of pharmacologically-induced mydriasis

September 27th 2023

What to expect from virtual AAO 2020

November 5th 2020

World Retina Day: New data from Kiora Pharmaceuticals shines a light on inherited retinal diseases

September 25th 2023

Foundation Fighting Blindness awards $900,000 to MitoChem Therapeutics to study target and mechanism of action in retinal degeneration disease

September 25th 2023

ProQR Therapeutics offers update on sale of ophthalmic assets

September 29th 2023

Integrating AI to manage DR in a primary care setting

December 1st 2020

FDA approves RYZUMVI (Phentolamine Ophthalmic Solution) for the treatment of pharmacologically-induced mydriasis

September 27th 2023

What to expect from virtual AAO 2020

November 5th 2020

World Retina Day: New data from Kiora Pharmaceuticals shines a light on inherited retinal diseases

September 25th 2023

Foundation Fighting Blindness awards $900,000 to MitoChem Therapeutics to study target and mechanism of action in retinal degeneration disease

September 25th 2023

ProQR Therapeutics offers update on sale of ophthalmic assets

September 29th 2023

Integrating AI to manage DR in a primary care setting

December 1st 2020

FDA approves RYZUMVI (Phentolamine Ophthalmic Solution) for the treatment of pharmacologically-induced mydriasis

September 27th 2023

What to expect from virtual AAO 2020

November 5th 2020

World Retina Day: New data from Kiora Pharmaceuticals shines a light on inherited retinal diseases

September 25th 2023

Foundation Fighting Blindness awards $900,000 to MitoChem Therapeutics to study target and mechanism of action in retinal degeneration disease

September 25th 2023
© 2023 MJH Life Sciences

All rights reserved.